BRL Medicine Inc. achievements were selected into the second edition of blue book of thalassemia in China
2021-05-12
BRL Medicinewas awarded "China future healthcare ranking 2020-2021—Top 100"
2021-04-20
World's first clinical trial of non-viral PD1 specific targeted CAR-T therapy achieves great breakthroughs
2020-09-25
The world's first CRISPR gene editing treatment of β0/β0 type thalassemia is successful
2020-07-24
Scientists in BRL Medicine reported a novel two-base editing system in Nature Biotechnology
2020-05-27
